We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
+$45.4B
Cap. Flow %
6.09%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Technology 1.89%
2 Consumer Discretionary 1.29%
3 Communication Services 0.93%
4 Healthcare 0.89%
5 Financials 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGHL
12126
PUT
Lion Group Holding
LGHL
$514K
0
RCON icon
12127
PUT
Recon Technology
RCON
$820K
$76K ﹤0.01%
7
SLE icon
12128
CALL
Super League Enterprise
SLE
$182M
$76K ﹤0.01%
3
-2
-40% -$78.8K
FRES
12129
DELISTED
Fresh2 Group Limited American Depositary Shares
FRES
$76K ﹤0.01%
+117
New +$88.8K
VNTR
12130
DELISTED
Venator Materials PLC
VNTR
$76K ﹤0.01%
26,669
-400,237
-94% -$1.28M
NAVB
12131
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$76K ﹤0.01%
43,445
+1,513
+4% +$2.55K
BKYI
12132
CALL
BIO-key International
BKYI
$4.25M
$75K ﹤0.01%
+118
New +$69.6K
TEF
12133
CALL
DELISTED
Telefonica
TEF
$75K ﹤0.01%
17,151
+5,359
+45% +$23.8K
TRUE
12134
CALL
DELISTED
TrueCar
TRUE
$75K ﹤0.01%
18,100
-7,400
-29% -$34.3K
SOLOW
12135
DELISTED
Electrameccanica Vehicles Corp. Ltd. Warrants
SOLOW
$75K ﹤0.01%
+54,582
New +$81.1K
EMX
12136
DELISTED
EMX Royalty
EMX
$74K ﹤0.01%
28,957
+12,814
+79% +$36.6K
FENG
12137
CALL
Phoenix New Media
FENG
$17.8M
$73K ﹤0.01%
9,550
+383
+4% +$3.13K
HALL
12138
CALL
DELISTED
Hallmark Financial Services, Inc.
HALL
$73K ﹤0.01%
2,000
-1,800
-47% -$76.4K
FSTX
12139
PUT
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$73K ﹤0.01%
+10,000
New +$68.6K
ELOX
12140
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$73K ﹤0.01%
1,126
+357
+46% +$22K
AIM
12141
AIM ImmunoTech
AIM
$7.61M
$73K ﹤0.01%
+362
New +$73.1K
CELU icon
12142
PUT
Celularity
CELU
$25.5M
$72K ﹤0.01%
1,020
-290
-22% -$23.4K
LSAK icon
12143
CALL
Lesaka Technologies
LSAK
$390M
$72K ﹤0.01%
15,500
-100
-0.6% -$438
SBT
12144
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$72K ﹤0.01%
+14,028
New +$70.4K
CLBTW
12145
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
$72K ﹤0.01%
+33,333
New +$76.7K
LJPC
12146
PUT
DELISTED
La Jolla Pharmaceutical Company
LJPC
$72K ﹤0.01%
18,000
-4,300
-19% -$17.1K
MBAI
12147
Check-Cap
MBAI
$9.33M
$71K ﹤0.01%
+576
New +$85.3K
DHX icon
12148
PUT
DHI Group
DHX
$193M
$71K ﹤0.01%
15,000
+4,000
+36% +$15.7K
EMAN
12149
PUT
DELISTED
eMagin Corporation
EMAN
$71K ﹤0.01%
31,400
+600
+2% +$1.59K
ASPU
12150
CALL
DELISTED
ASPEN GROUP, INC.
ASPU
$71K ﹤0.01%
+12,800
New +$77.3K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass deployed $45.4B of net new capital in Q3 2021, opening 1,741 new positions and adding to 5,205 existing holdings. Its largest new stake was InMode: 613,660 shares worth $48.9M.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Walt Disney, an estimated $2.17B trimmed.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.